| MPD | main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe... |
|---|---|
| MPL | maximum permissible level; melphalan; mesiopulpolingual; myeloproliferative leukemia |
| MPO | maximum power output; minimal perceptible odor; myeloperoxidase |
| MPR | mannose 6-phosphate receptor; marrow production rate; massive preretinal retraction; maximum pulse r... |
| MRC | maximum recycling capacity; Medical Registration Council; Medical Research Council; Medical Reserve ... |
| quinine and urea hydrochloride | Sclerosing agent for treatment of internal haemorrhoids, hydrocele, and varicose veins, containing not less than 58% and not more than 65% of anhydrous quinine. (05 Mar 2000) |
|---|---|
| information storage and retrieval | A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject. (12 Dec 1998) |
| injuries, poisonings, and occupational diseases | Disorders representing collectively the results of assault by external forces, rather than by organic or physiologic dysfunction or by pathogens. (12 Dec 1998) |
| insect bites and stings | Bites and stings inflicted by insects. (12 Dec 1998) |
| interior design and furnishings | The planning of the furnishings and decorations of an architectural interior. (12 Dec 1998) |
| International Classification of Impairments Disabilities and Handicaps | A WHO-sponsored numerical taxonomy of the impairments, disabilities and handicaps consequent upon injury and disease. (05 Mar 2000) |
| internship and residency | Programs of training in medicine and medical specialties offered by hospitals for graduates of medicine to meet the requirements established by accrediting authorities. (12 Dec 1998) |
| obstetrics and gynecology department, hospital | Hospital department responsible for the administration and management of services provided for obstetric and gynecologic patients. (12 Dec 1998) |
| occupational safety and health administration | One of the U.S. Agencies responsible for regulation of biotechnology. The major law under which the agency has regulatory powers is the Occupational Safety and Health act. (09 Oct 1997) |
| oesophageal and gastric varices | Submucosal varices of the lower oesophagus or gastric fundus mucosa, frequently caused by the development of portal collateral vessels consequent to portal hypertension. (12 Dec 1998) |
| oesophageal webs and rings | <radiology> Congenital web, web secondary to bullous disease, cervical web, Plummer-Vinson (Patterson-Kelly) syndrome, mucosal (Schatzki) ring (12 Dec 1998) |
| organization and administration | The planning and managing of programs, services, and resources. (12 Dec 1998) |
| outcome and process assessment | Evaluation procedures that focus on both the outcome or status (outcome assessment) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (process assessment) - what is done for the patient diagnostically and therapeutically. (12 Dec 1998) |
| task performance and analysis | The detailed examination of observable activity or behaviour associated with the execution or completion of a required function or unit of work. (12 Dec 1998) |
| tax equity and fiscal responsibility act | Pl97-248. Title II of the act specifies "provisions relating to savings in health and income security programs." this includes changes in payment for services, benefits and premiums of medicare as well as changes in provisions under medicaid and other specific programs covered by social security. Title II includes various revenue measures. (12 Dec 1998) |